Target Price | $9.90 |
Price | $2.96 |
Potential |
234.46%
register free of charge
|
Number of Estimates | 10 |
10 Analysts have issued a price target Zentalis Pharmaceuticals Inc 2025 .
The average Zentalis Pharmaceuticals Inc target price is $9.90.
This is
234.46%
register free of charge
$20.00
575.68%
register free of charge
$4.00
35.14%
register free of charge
|
|
A rating was issued by 11 analysts: 4 Analysts recommend Zentalis Pharmaceuticals Inc to buy, 7 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Zentalis Pharmaceuticals Inc stock has an average upside potential 2025 of
234.46%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Revenue Million $ | 0.00 | 40.62 |
11 Analysts have issued a sales forecast Zentalis Pharmaceuticals Inc 2024 . The average Zentalis Pharmaceuticals Inc sales estimate is
This results in the following potential growth metrics:
2 Analysts have issued an Zentalis Pharmaceuticals Inc EBITDA forecast 2024. The average Zentalis Pharmaceuticals Inc EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
11 Zentalis Pharmaceuticals Inc Analysts have issued a net profit forecast 2024. The average Zentalis Pharmaceuticals Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share $ | -4.47 | -2.90 |
0.22% | 35.12% | |
P/E | negative | |
EV/Sales | negative |
11 Analysts have issued a Zentalis Pharmaceuticals Inc forecast for earnings per share. The average Zentalis Pharmaceuticals Inc <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the Zentalis Pharmaceuticals Inc stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Zentalis Pharmaceuticals Inc...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.